Both IL-6 and IL-8 have been implicated in the pathogenesis and progression of several solid tumor types, including breast [6], prostate [7], colon [8], and pancreatic [9] cancers, and indeed elevated expression of both molecules has been associated with increased cancer aggressiveness and metastatic burden [8,10,11]. Here, IL6 is linked to cancer.